Original Research

DOI: 10.4244/EIJ-D-23-00490

Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry

Giuseppe Vadalà1, MD; Alfredo R. Galassi2, MD; Gerald S. Werner3, MD, PhD; George Sianos4, MD; Nicolaus Boudou5, MD; Roberto Garbo6, MD; Laura Maniscalco1, PhD; Alexander Bufe7, MD; Alexander Avran8, MD; Gabriele L. Gasparini9, MD; Eugenio La Scala10, MD; Andrew Ladwiniec11, MD; Meruzhan Saghatelyan12, MD; Omer Goktekin13, MD, PhD; Sevket Gorgulu14, MD; Nicolaus Reifart15, MD, PhD; Pierfrancesco Agostoni16, MD; Sudhir Rathore17, MD; Mohamed Ayoub18, MD; Michael Behnes19, MD; Iskander Atmowihardjo20, MD; Mario Iannaccone21, MD; Roberto Diletti22, MD; Carlo Di Mario23, MD, PhD; Kambis Mashayekhi24,25, MD, PhD; on behalf of the EURO CTO investigators

Abstract

BACKGROUND: Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) have reached high procedural success rates thanks to dedicated equipment, evolving techniques, and worldwide adoption of state-of-the-art crossing algorithms.

AIMS: We report the contemporary results of CTO PCIs performed by a large European community of experienced interventionalists. Furthermore, we investigated the impact of different risk factors for procedural major adverse cardiac and cerebrovascular events (MACCE) and trends of employment of specific devices like dual lumen microcatheters, guiding catheter extensions, intravascular ultrasound and calcium-modifying tools.

METHODS: We evaluated data from 8,673 CTO PCIs included in the European Registry of Chronic Total Occlusion (ERCTO) between January 2021 and October 2022.

RESULTS: The overall technical success rate was 89.1% and was higher in antegrade as compared with retrograde cases (92.8% vs 79.3%; p<0.001). Compared with antegrade procedures, retrograde procedures had a higher complexity of attempted lesions (Japanese CTO [J-CTO] score: 3.0±1.0 vs 1.9±1.2; p<0.001), a higher procedural and in-hospital MACCE rate (3.1% vs 1.2%; p<0.018) and a higher perforation rate with and without tamponade (1.5% vs 0.4% and 8.3% vs 2.1%, respectively;...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 3
Feb 5, 2024
Volume 20 Number 3
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-24-00030 Jul 15, 2024
Ultrasound is not the panacea for transfemoral access complications
Jolly S and d'Entremont M
free

Viewpoint

10.4244/EIJ-D-24-00205 Jul 15, 2024
Subclinical leaflet thrombosis: should we be concerned?
Dangas G and Bay B
free

Viewpoint

10.4244/EIJ-D-24-00164 Jul 15, 2024
TAVI in moderate aortic stenosis: the earlier the better?
Schofer N and Ludwig S
free

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free

Original Research

10.4244/EIJ-D-23-00882 Jul 15, 2024
Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease
Scarparo P et al
Trending articles
94.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
56.5

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
55.1

Clinical Research

10.4244/EIJ-D-21-00875 Aug 5, 2022
Features of atherosclerosis in patients with angina and no obstructive coronary artery disease
Pellegrini D et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved